AJO LP increased its position in shares of LifeVantage Corp (NASDAQ:LFVN) by 6.2% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 242,223 shares of the company’s stock after buying an additional 14,195 shares during the quarter. AJO LP owned 1.70% of LifeVantage worth $3,461,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of LFVN. BlackRock Inc. increased its stake in LifeVantage by 210.9% during the 3rd quarter. BlackRock Inc. now owns 238,160 shares of the company’s stock worth $2,618,000 after acquiring an additional 161,555 shares during the period. Acadian Asset Management LLC increased its holdings in LifeVantage by 25.4% during the 1st quarter. Acadian Asset Management LLC now owns 364,749 shares of the company’s stock worth $5,211,000 after purchasing an additional 73,992 shares in the last quarter. Barclays PLC increased its holdings in LifeVantage by 5,830.2% during the 4th quarter. Barclays PLC now owns 61,200 shares of the company’s stock worth $807,000 after purchasing an additional 60,168 shares in the last quarter. Vanguard Group Inc grew its holdings in shares of LifeVantage by 13.4% in the third quarter. Vanguard Group Inc now owns 502,155 shares of the company’s stock valued at $5,519,000 after acquiring an additional 59,155 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of LifeVantage by 13.4% in the third quarter. Vanguard Group Inc. now owns 502,155 shares of the company’s stock valued at $5,519,000 after acquiring an additional 59,155 shares in the last quarter. 37.31% of the stock is owned by hedge funds and other institutional investors.
LifeVantage stock traded up $0.38 during trading on Monday, hitting $13.36. The stock had a trading volume of 299,800 shares, compared to its average volume of 135,464. LifeVantage Corp has a 1 year low of $6.00 and a 1 year high of $17.08. The company’s 50 day moving average price is $11.60. The firm has a market cap of $197.06 million, a PE ratio of 26.08 and a beta of 0.70.
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.
Further Reading: Oversold
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.